Drug: CLONIDINE TRANSDERMAL SYSTEM Injury: Application site rash Quarter: 2016Q3
Total Records: 6 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
114233892 | CLONIDINE TRANSDERMAL SYSTEM | Application site rash | MYLAN | 0.00 | M | 83 KG | 20160823 | US |
126770571 | CLONIDINE TRANSDERMAL SYSTEM | Application site rash | MYLAN | 0.00 | F | 0 | 20160823 | US |
126770861 | CLONIDINE TRANSDERMAL SYSTEM | Application site rash | MYLAN | 69.87 YR | F | 0 | 20160823 | US |
126770891 | CLONIDINE TRANSDERMAL SYSTEM | Application site rash | MYLAN | 0.00 | F | 0 | 20160823 | US |
126770901 | CLONIDINE TRANSDERMAL SYSTEM | Application site rash | MYLAN | 0.00 | F | 0 | 20160823 | US |
126770941 | CLONIDINE TRANSDERMAL SYSTEM | Application site rash | MYLAN | 61.71 YR | F | 0 | 20160823 | US |
Total Records: 6 Number of Pages: 1